Multi-center MRD Registry for Inflammatory Breast Cancer

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06966050
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Quality-of-life Questionnaire — BEHAVIORAL
    Participants will be asked to fill out a quality-of-life questionnaire, which will take about 10-15 minutes to complete.

Study Details

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Key Dates

Start date
May 5, 2025
Status verified
May 2026
Primary completion
May 31, 2030
Completion
May 31, 2032

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Group 1
    Participants will fill out a quality-of-life questionnaire and complete a MRD test.

Primary Outcome Measure

European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Sadia Saleem, MD
[email protected]
281-566-1900
Angela Alexander
[email protected]
713-792-9137
Sadia Saleem, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
MD Anderson Cancer Center· Houston, TX

Related Studies